[Urinary excretion of 3,4-dihydroxyphenyl-alanine, 3-O-methyldopa, dopamine and homovanillic acid in man. Effects of an inhibitor of decarboxylase of aromatic amino acids (Benserazide) (author's transl)].
After administration of a single and small (125 mg) dose of benserazide, 3,4-dihydroxyphenyl-alanine and 3-O-methyldopa are excreted in urine. Uturbancies last for at least 48 hours.
D000328:Adult; D001545:Benserazide / Q000494:pharmacology*; D004295:Dihydroxyphenylalanine / Q000652:urine*; D004298:Dopamine / Q000652:urine*; D005260:Female; D006719:Homovanillic Acid / Q000652:urine*; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology*; D008297:Male; D008750:Methyldopa / Q000652:urine*; D010648:Phenylacetates / Q000652:urine*; D013997:Time Factors
D006834:Hydrazines; D010648:Phenylacetates; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D001545:Benserazide; D004298:Dopamine; D006719:Homovanillic Acid
Excretion Urinaire de 3,4-Dihyroxyphenyl-alanine, de 3-O-Methyldopa, de Dopamine et d'Acide Homovanillique chez l'Homme. Effet d'un Inhibiteur de la Decarboxylase des Acides Amines Aromatiques (Bensérazide)